|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Pyridoxal 5- Phosphate Concentration
Test Code10376
CPT Codes
84207<br /> Limited Access Code
Preferred Specimen
1 mL CSF collected in a sterile screw-cap vial
Minimum Volume
0.5 mL
Instructions
Collect entire sample in a single sterile tube: FREEZE IMMEDIATELY after collection, Sample stability is limited.
Recommended MNG Kits: CSF Collection Tubes (set of 5 tubes per kit)
Recommended MNG Kits: CSF Collection Tubes (set of 5 tubes per kit)
Transport Temperature
Frozen
Specimen Stability
Room temperature: Not stable
Refrigerated: Not stable
Frozen -20° C: 72 hours
Frozen -80° C: Indefinitely
Refrigerated: Not stable
Frozen -20° C: 72 hours
Frozen -80° C: Indefinitely
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Bloody CSF • Received thawed
Methodology
HPLC/Fluorescence
FDA Status
This test was developed and its performance characteristics determined by Medical Neurogenetics, LCC. It has not been cleared or approved by the U.S. FDA.
Setup Schedule
Set up: Varies; Report available: 10-14 days
Reference Range
Age (years) | nmol/L |
0-0.25 | 30-80 |
0.26-1 | 23-65 |
1.01-4 | 15-51 |
4.01-Adult | 10-37 |
Clinical Significance
CSF Pyridoxal 5'-phosphate is useful for diagnosis of disorders leading to low CSF levels of this cofactor. This testing may also be used for assessment of Variants of Uncertain Significance (VUS) identified during genetic testing (e.g. Next Generation Sequencing or Capillary Sequencing Testing). CLINICAL Pryridoxal 5'phosphate (PLP) (a member of the vitamin B6 family) is required as a cofactor for over 100 different enzymes in the body. These may involve the metabolism of various neurotransmitters and amino acids. Inadequate PLP may occur due to genetic, nutritional deficiencies as well as reaction with various drugs. Inherited disorders that affect the CSF PLP level include pyridox(am)ine phosphate oxidase (PNPO) deficiency, alpha aminoadipic semialdehyde dehydrogenase deficiency, hyperprolinermia type 2 and hypophoshatasia due to alkaline phosphatase deficiency.